Fusidic acid prices in the US weakened during June as subdued pharmaceutical demand and competitive seller pricing outweighed rising logistics costs. Demand remained largely confined to clinical-trial applications and compounding pharmacies, while hospitals continued to prefer lower-cost topical alternatives, limiting broader procurement activity. Asian suppliers reduced export offers to clear inventories, further pressuring market prices despite higher freight expenses. On the supply side, improved export documentation procedures accelerated shipments from China and India, while sufficient inventories and steady European production ensured comfortable product availability. Although container freight costs increased, supplier discounts offset much of the additional logistics burden, resulting in lower landed prices. Looking ahead, the Fusidic acid market is expected to remain soft in the near term due to ample inventories, cautious purchasing, and steady import arrivals. However, gradual restocking, firmer import costs, and seasonal procurement later in the year could provide moderate support to Fusidic acid prices, subject to prevailing market conditions.
Fusidic acid prices in the US moved lower in June as softer pharmaceutical demand coincided with easier seller positioning and ongoing logistical challenges. Early June trading in the Fusidic acid market remained largely limited to clinical-trial requirements and compounding pharmacies, while hospital formularies continued to favor lower-priced topical alternatives, restricting broader procurement. During mid-June, procedural relief on export documentation and increased seller discounts from Asian suppliers shortened lead times for shipments but failed to generate significant import demand. Meanwhile, sharply higher Shanghai–Houston container freight rates, which increased by around *** during the month, raised landed logistics costs for some buyers. By late June, the Fusidic acid market shifted toward clearing surplus inventories rather than competing for limited availability, resulting in a notable monthly price correction despite continued logistical cost pressures.
The pharmaceutical sector remained the primary demand driver for Fusidic acid, although overall consumption...
Leave a Comment
Comments (0)